Novartis Investigative Site

Manitowoc, Wisconsin 54220

0 studies enrolling now · 2 studies all time

What they study most

Ankylosing Spondylitis, Heart Failure and Reduced Ejection Fraction

Studies at this site

• Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis — Completed
• Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction — Completed